Literature DB >> 11692187

Mutations of the peroxisome proliferator-activated receptor gamma (PPAR gamma) gene in a Japanese population : the Pro12Ala mutation in PPAR gamma 2 is associated with lower concentrations of serum total and non-HDL cholesterol.

E Iwata, H Matsuda, T Fukuda, S Fukuen, T Motomura, T Igarashi, I Yamamoto, J Azuma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11692187     DOI： 10.1007/s001250100647

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  5 in total

1.  Gender, body mass index, and PPARγ polymorphism are good indicators in hyperuricemia prediction for Han Chinese.

Authors:  Ming-Fen Lee; Tsan-Hon Liou; Weu Wang; Wen-Harn Pan; Wei-Jei Lee; Chung-Tan Hsu; Suh-Fen Wu; Hsin-Hung Chen
Journal:  Genet Test Mol Biomarkers       Date:  2013-01

2.  Genotype-based recall to study metabolic effects of genetic variation: a pilot study of PPARG Pro12Ala carriers.

Authors:  Prasad G Kamble; Stefan Gustafsson; Maria J Pereira; Per Lundkvist; Naomi Cook; Lars Lind; Paul W Franks; Tove Fall; Jan W Eriksson; Erik Ingelsson
Journal:  Ups J Med Sci       Date:  2018-01-05       Impact factor: 2.384

3.  Role of peroxisome proliferator-activated receptor gamma Pro12Ala polymorphism in human adipose tissue: assessment of adipogenesis and adipocyte glucose and lipid turnover.

Authors:  Prasad G Kamble; Maria J Pereira; Stefan Gustafsson; Per Lundkvist; Casimiro Castillejo-López; Tove Fall; Erik Ingelsson; Jan W Eriksson
Journal:  Adipocyte       Date:  2018-08-14       Impact factor: 4.534

4.  PPARγ2 polymorphism and human health.

Authors:  Weimin He
Journal:  PPAR Res       Date:  2009-04-16       Impact factor: 4.964

5.  PPAR α and PPAR γ polymorphisms as risk factors for dyslipidemia in a Chinese Han population.

Authors:  Shu-Jun Gu; Zhi-Rong Guo; Zheng-Yuan Zhou; Xiao-Shu Hu; Ming Wu
Journal:  Lipids Health Dis       Date:  2014-01-26       Impact factor: 3.876
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.